Serena Bright™

Contrast-guided biopsy solution

Utilizes contrast-spectral mammography to clearly target and biopsy lesions without leaving the mammography suite.

At a glance

Fast procedure

CEM biopsy can be done within 15 minutes1.

Patient preferred

2 out of 3 patients prefer CEM to MRI2.

Lower cost

MRI diagnostic with biopsy is 51%3 more costly than CEM diagnostic & biopsy.

Efficient

Switch to interventional on the same system within your current room in 2 minutes4.

See and biopsy what matters

Serena Bright enables providers to see lesions using contrast-enhanced mammography (CEM) and sample with certainty. This allows patients to undergo breast biopsy exams using the same mammography equipment, in a familiar setting, with familiar staff, to help relieve some of the stress of a biopsy procedure.

See and biopsy what matters

Serena Bright  enables providers to see lesions using contrast-enhanced mammography (CEM) and sample with certainty. This allows patients to undergo breast biopsy exams using the same mammography equipment, in a familiar setting, with familiar staff, to help relieve some of the stress of a biopsy procedure.
OPTIMIZED FOR ACCURACY

More confidence in biopsy

Avoid the challenges of seeking correlating lesions in MRI. CEM allows you to see lesions clearly and sample with certainty with the same image guidance.
CLARITY WITH COMPLEMENTARY IMAGING

Compare like to like for increased biopsy correlation

With high sensitivity and specificity, CEM helps drive accuracy in biopsy. It allows you to clearly target suspicious areas by correlating lesion locations already identified in your patient’s diagnostic enhanced mammogram.
FIND ANSWERS SOONER

Shorten the time to biopsy and diagnosis

No more delays waiting for MRI availability or enduring lengthy 60-90 minute5 MRI-guided breast biopsy procedures. CEM guided biopsy can be performed within 15 minutes from first image to clip placement image6. A shorter biopsy lead time and quicker biopsy procedure may speed up a definitive diagnosis and faster path to treatment.
FUTURE-FOCUSED

Ready today. Prepared for tomorrow

Pristina Serena is highly adaptable and designed to support future functionalities, positioning you for long-term success. The advanced features allow you to work within your current space and the technology is compatible with common biopsy devices.
RELATED CONTENT

Latest insights

 

What to expect

Learn more about the patient experience with CEM biopsy.

 

Listen to your peers

Clinicians share the power of CEM in biopsy.

 

What colleagues are saying

Discover reasons why you should consider CEM biopsies.

 

Transform your practice

Discover our comprehensive CEM offer.

RELATED PRODUCTS

Discover our breast care solutions

GE HealthCare continues to innovate and improve the mammography experience through Senographe Pristina and supporting products for imaging review, biopsy, and contrast-enhanced mammography.

Get in touch

Have a question? We would like to hear from you.

References
1. Data on file 2020, GE HealthCare; time from first to last image.

2. Hobbs et al., Contrast-enhanced spectral mammography (CESM) and contrast enhanced MRI (CEMRI): Patient preferences and tolerance, J Med Imaging Radiat Oncol. 2015.

3. CESM Biopsy vs MR Biopsy Cost Analysis. Data on file. GE HealthCare 2020.

4. Data on file 2019, GE HealthCare.

5. https://www.cedars-sinai.edu/Patients/Programs-and-Services/Imaging-Center/For-Patients/Exams-by-Procedure/MRI/MRGuided-Breast-Biopsy/MR-Guided-Breast-Needle-Core-Biopsy-Procedure-Information.aspx

6. Data on file 2020, GE HealthCare.

* Superior diagnostic accuracy demonstrated in a reader study comparing the ROC AUC of GE screening protocol (V-Preview + 3D CC/MLO with 3D in STD mode) to that of 2D FFDM alone. V-Preview is the 2D synthesized image generated by GE Seno Iris mammography software from GE DBT images. FDA PMA P130020 http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpma/pma.cfm?id=P130020.

** As compared to Pristina Serena 2D biopsy. Data on file GE HealthCare 2018.

JB25283XX